Effects of Cognitive Behavior Language Therapy for Patients With Post Stroke Aphasia

This study is clinical trial based and the target population in this study is patients with post-stroke aphasia. Cognitive linguistic quick test (CLQT) and Speech Language unhelpful thoughts and belief scale (SLUTBS) will apply as an assessment. Inclusive criteria include diagnosed male and female post-stroke severe aphasia patients above 30 years of age. These participants must have high instance of unhelpful speech language thoughts and belief. Participants in inclusive criteria must not be participated in any other psychotherapy/ speech language intervention program. Participants must sign an informed consent form. Participants having a caregiver who is willing to be present during the period of intervention. Exclusive criteria include individuals below 30 years of age and patients with aphasia caused by non-stroke etiology.

The aim of the study is to check the effects of cognitive behavior language therapy on patients with post-stroke aphasia. So, it will help speech language pathologists to adopt the principles of CBLT intervention to treat aphasia that occurs as a result of aphasia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Aphasia Communication Disorders Language Disorders Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Speech Disorders

Age range

30 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sheikh Zaid

Rahim Yar Khan, Punjab Province, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Both male and female.
Over 30 years of age.
All types of diagnosed aphasia.
Severe aphasia following stroke.
High instance of unhelpful speech language thoughts and belief.
Participants who are not participating in any other psychotherapy / speech language intervention program will be included.
Participants who are willing to sign an informed consent form.
Participants having a caregiver who is willing to be present during the period of intervention.

Exclusion criteria

Below 30 years of age.
Patients with aphasia caused by a non-stroke etiology.

Treatment and study plan

cognitive behavior language therapy

Behavioral

Cognitive behavior language therapy is an extensive form of Cognitive behavior therapy. and it is used in the management of speech-language related problems. It helps the individuals to change their unhelpful thoughts and beliefs that cause difficulty for them to communicate properly and effectively. and it also helps the individuals to use their remaining language abilities, to restore their language abilities and to learn the other ways of communication i.e. pointing, gesturing and Augmentative alternative communication.

Primary outcomes

Cognitive linguistic quick test

Time frame: 4 week

scoring 3.5 to 4 indicates attention, memory, executive functions, language, visuospatial skills are within the normal limit. whereas scoring 1 to 1.4 indicates that individual has severely affected in these areas.
Speech language and helpful thoughts and belief scale

Time frame: 4 week

the scoring of this scale according to 4. Likert scale. In which ''4'' strongly agree indicates high communication gap while sharing thoughts with others and ''1'' strongly disagree indicates individuals haven't facing any difficulties while sharing thoughts.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Jan 26, 2023
Registry last updated: Dec 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed